Solventum logo

SolventumNYSE: SOLV

Profile

Sector:

Healthcare

Country:

United States

IPO:

01 April 2024

Next earnings report:

28 February 2025

Last dividends:

N/A

Next dividends:

N/A
$11.25 B
-15%vs. 3y high
93%vs. sector
176.86
-15%vs. 3y high
97%vs. sector
-19%vs. 3y high
73%vs. sector
-15%vs. 3y high
29%vs. sector

Price

pre-market | 53 min ago
$65.12-$1.57(-2.35%)

Dividend

No data over the past 3 years
$2.08 B$2.05 B
$2.08 B$122.00 M

Analysts recommendations

Institutional Ownership

SOLV Latest News

Solventum to Participate in the Piper Sandler Healthcare Conference
prnewswire.com19 November 2024 Sentiment: -

ST. PAUL, Minn., Nov. 19, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that its executives will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024 at 11:30 a.m.

SOLV Stock Falls Despite Launch of Clarity Precision Grip Attachments
zacks.com15 November 2024 Sentiment: POSITIVE

Solventum's Clarity precision grip attachments improve results for orthodontic patients by lowering the chances of incorrect or poorly shaped attachments.

Solventum Corporation (SOLV) Q3 2024 Earnings Call Transcript
seekingalpha.com08 November 2024 Sentiment: NEUTRAL

Solventum Corporation (NYSE:SOLV) will hold its Q3 2024 Earnings Conference Call on November 7, 2024, at 4:30 PM ET. The call will feature company representatives including Kevin Moran, Bryan Hanson, and Wayde McMillan, along with analysts from various financial institutions. The operator for the call is Amy, who will assist participants throughout the session.

SOLV Stock Gains as Q3 Earnings & Sales Beat Estimates, '24 View Up
zacks.com08 November 2024 Sentiment: POSITIVE

Solventum's revenue shows positive effects from adjusted pricing. The main reason for organic growth is the increasing demand for MedSurg products.

Solventum raises annual profit forecast on strong surgical product sales
reuters.com07 November 2024 Sentiment: POSITIVE

On Thursday, Solventum, a company that spun off from 3M, increased its yearly profit expectations due to anticipated high sales of its wound care and surgical sterilization items.

Solventum Q3 Earnings Likely to Reflect Declining Volume Trend
zacks.com06 November 2024 Sentiment: NEUTRAL

SOLV's performance in the third quarter may have been negatively affected by slow revenue growth in various markets and challenges with currency exchange rates. However, better pricing strategies could have helped reduce the impact of falling sales.

Solventum Taps Bankers to Explore Sale of Filtration Unit
wsj.com24 October 2024 Sentiment: POSITIVE

The company is likely to attract interest from private equity firms and strategic buyers looking to acquire it.

Will Solventum (SOLV) Beat Estimates Again in Its Next Earnings Report?
zacks.com15 October 2024 Sentiment: POSITIVE

Solventum (SOLV) has a strong track record of surprising with its earnings and currently has the right mix of factors that suggest it may exceed expectations in its upcoming quarterly report.

Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
prnewswire.com15 October 2024 Sentiment: NEUTRAL

ST. PAUL, Minn., Oct. 15, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) is set to announce its financial results for the third quarter of 2024 on Thursday, November 7, 2024, after the U.S. markets have closed.

Solventum Names Surgeon and Diagnostics Pioneer Dr. Ryan Egeland as Chief Medical Officer
prnewswire.com10 October 2024 Sentiment: POSITIVE

ST. PAUL, Minn., Oct. 10, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) has announced that Dr. Ryan Egeland, MD, will be taking on the role of chief medical officer.

  • 1(current)

What type of business is Solventum?

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

What sector is Solventum in?

Solventum is in the Healthcare sector

What industry is Solventum in?

Solventum is in the Health Information Services industry

What country is Solventum from?

Solventum is headquartered in United States

When did Solventum go public?

Solventum initial public offering (IPO) was on 01 April 2024

What is Solventum website?

https://www.solventum.com

Is Solventum in the S&P 500?

Yes, Solventum is included in the S&P 500 index

Is Solventum in the NASDAQ 100?

No, Solventum is not included in the NASDAQ 100 index

Is Solventum in the Dow Jones?

No, Solventum is not included in the Dow Jones index

When was Solventum the previous earnings report?

No data

When does Solventum earnings report?

The next expected earnings date for Solventum is 28 February 2025